Trichlormethiazide and Repaglinide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Trichlormethiazide (trichlormethiazide) and Repaglinide (repaglinide). Common drug interactions include arthralgia among females and abdominal distension among males.

The phase IV clinical study analyzes what interactions people have when they take Trichlormethiazide and Repaglinide. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Trichlormethiazide?

Trichlormethiazide has active ingredients of trichlormethiazide. eHealthMe is studying from 2,613 Trichlormethiazide users. Check the latest studies of Trichlormethiazide.

What is Repaglinide?

Repaglinide has active ingredients of repaglinide. It is often used in diabetes. eHealthMe is studying from 8,226 Repaglinide users. Check the latest studies of Repaglinide.

On Jul, 21, 2026

20 people who take Trichlormethiazide and Repaglinide together, and have interactions are studied.

Trichlormethiazide and Repaglinide drug interactions.

What are the common drug interactions of Trichlormethiazide and Repaglinide, by gender? *:

female:

Arthralgia (joint pain)
Pneumonia
Abnormal faeces (abnormal stool)
Acute respiratory failure
Aortic arteriosclerosis (hardening of the aortic arteries)
Aortic disorder
Basophil count increased
Blood glucose increased
Blood magnesium increased
Blood potassium increased

male:

Abdominal distension
Constipation
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
Cardiac failure congestive
Cardiomegaly (increased size of heart than normal)
Cataract (clouding of the lens inside the eye)
Cholangitis acute (rapid infection of bile duct)
Diabetic retinopathy (damage to the retina caused by complications of diabetes)
Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)

What are the common drug interactions of Trichlormethiazide and Repaglinide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Alanine aminotransferase increased
Aortic valve incompetence
Aspartate aminotransferase increased
Blood glucose increased
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
Cardiac failure congestive
Cardiomegaly (increased size of heart than normal)
Cataract (clouding of the lens inside the eye)
Diabetic retinopathy (damage to the retina caused by complications of diabetes)
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)

60+:

Arthralgia (joint pain)
Pneumonia
Blood urea increased
Bone callus excessive (excessive bony deposit formed between and around the broken ends of bone fractures)
Contusion (a type of hematoma of tissue in which capillaries)
Femur fracture
Flatulence (flatus expelled through the anus)
Haemoglobin decreased
Injury
Joint range of motion decreased (disease of joint movement)

What are the existing conditions these people have? *

Type 2 Diabetes: 15 people, 75.00%
High Blood Pressure: 12 people, 60.00%
Productive Cough: 11 people, 55.00%
Arrhythmias (irregular heartbeat): 11 people, 55.00%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 11 people, 55.00%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 11 people, 55.00%
Insomnia (sleeplessness): 11 people, 55.00%
Cough: 8 people, 40.00%
Back Pain: 5 people, 25.00%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 5 people, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Trichlormethiazide and Repaglinide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously